Innovation Pharmaceuticals Announces Publication of Peer-Reviewed Scientific Article in the Journal Viruses on the Anti-SARS-CoV-2 Properties of Brilacidin
02 mars 2021 09h00 HE
|
Innovation Pharmaceuticals Inc.
Emerging mutations to the coronavirus are unlikely to affect Brilacidin’s ability to inhibit the virusBrilacidin currently is being evaluated in a Phase 2 clinical trial in hospitalized COVID-19...
Insights on the Polymerase Chain Reaction for Point-of-Care Diagnostics Global Market to 2025 - Impact Analysis of COVID-19
11 févr. 2021 07h33 HE
|
Research and Markets
Dublin, Feb. 11, 2021 (GLOBE NEWSWIRE) -- The "Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics" report has been added to ResearchAndMarkets.com's offering. The scope of this...
Innovation Pharmaceuticals’ Phase 2 Clinical Trial of Brilacidin for Treating COVID-19 Scheduled to Begin Next Week
29 janv. 2021 09h15 HE
|
Innovation Pharmaceuticals Inc.
Brilacidin treatment unlikely to be impacted by coronavirus variants, such as those originating in the U.K., South Africa and Brazil, and spreading worldwide, due to its ability to attack the virus...
2020 Insights on the Worldwide Medical Devices & Diagnostics Industry to 2021 - Affects of COVID-19 on Companies Including Medtronic, Abbott Laboratories & GE Healthcare
21 janv. 2021 09h33 HE
|
Research and Markets
Dublin, Jan. 21, 2021 (GLOBE NEWSWIRE) -- The "The COVID Impact on Global Medical Devices & Diagnostics Markets: 2020 Review & 2021 Forecast" report has been added to...
United States Clinical Chemistry and Immunoassay In-Vitro Diagnostics Market Report 2020: Serology Assays for COVID-19 Diagnosis Present an Immediate Growth Opportunity
18 janv. 2021 09h18 HE
|
Research and Markets
Dublin, Jan. 18, 2021 (GLOBE NEWSWIRE) -- The "Demand for High-Volume Testing Driving the Growth of the US Clinical Chemistry and Immunoassay In Vitro Diagnostics Market, 2020" report has been added...
FluroTech Announces Joint Venture Product Solution and Partners
10 nov. 2020 08h45 HE
|
FluroTech Ltd.
CALGARY, Alberta, Nov. 10, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce, its previously announced joint venture...
FluroTech Formalizes Ownership Structure in FluroTest Joint Venture and Launches a Financing
05 nov. 2020 08h45 HE
|
FluroTech Ltd.
CALGARY, Alberta, Nov. 05, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that FluroTest, LLC (the “LLC”), a company in...
EndSARS Protest: Majority Condemns Killings and Offers Free Calls To And From Nigeria
22 oct. 2020 10h39 HE
|
MAJORITY
HOUSTON and STOCKHOLM, Oct. 22, 2020 (GLOBE NEWSWIRE) -- We are deeply saddened and concerned about the police brutality against protesters in Nigeria, which has already resulted in the deaths of at...
Global Coronavirus Diagnostics Market Report 2020-2025
30 sept. 2020 04h54 HE
|
Research and Markets
Dublin, Sept. 30, 2020 (GLOBE NEWSWIRE) -- The "Global Coronavirus Diagnostics Market by Type of Test (Molecular v/s Serology), by User (Single v/s Multiple), by Full Test Time (Less Than 60...
Clinical Trial Shows Itolizumab Reduces Mortality in Patients Hospitalized with COVID-19
13 juil. 2020 03h30 HE
|
Equillium
Equillium shares topline results of patients treated with itolizumab in clinical trial conducted in India by partner Biocon Biocon has received emergency use approval from Drugs Controller General of...